Document is current
Any future updates will be listed below
-
Authors
Wenstrup, Jonathan https://orcid.org/0000-0001-9604-4638
Havtorn, Jakob Drachmann https://orcid.org/0000-0002-4849-0817
Borgholt, Lasse https://orcid.org/0000-0002-3562-8442
Blomberg, Stig Nikolaj
Maaloe, Lars https://orcid.org/0000-0003-2030-520X
Sayre, Michael R. https://orcid.org/0000-0003-0322-3181
Christensen, Hanne https://orcid.org/0000-0002-7472-3194
Kruuse, Christina
Christensen, Helle Collatz https://orcid.org/0000-0003-3302-7149
-
Funding
Funding for this research was provided by:
TrygFonden
Herlev Hospital
Københavns Universitet
Innovationsfonden (0153-00167B, 2051-00015B)
Novo Nordisk Fonden (NNF18OC0031840)
- License Information
-
More Information
Article History
Received: 30 June 2023
Accepted: 29 November 2023
First Online: 19 December 2023
Competing interests
: J.D.H. and L.B. received funding from the Innovation Fund Denmark. J.D.H. and L.B. used Corti and held stock warrants. L.M. is a co-founder, stockholder, and the Chief Technology Officer of Corti. J.W. received funding from Trygfonden. S.N.F.B. has no conflicts of interest to declare. H.C. has received funding from the Velux Foundation, Tværsfonden, Helsefonden, Hartmann Fonden, Lundbeck Foundation, and Novo Nordisk Foundation; royalties from Gyldendal; honoraria from Bayer and Bristol Meyers Squibb, and is chair of Action Plan for stroke in Europe Implementation, Co-chair of the Scientific Stroke Panel EAN and Senior Guest Editor of AHA Stroke. M.S. has no conflicts of interest to declare. H.C.C. has no conflicts of interest to declare. C.K. received funding from the Novo Nordisk Foundation and is the chair of the Danish Resuscitation Council and vice chair of the Danish Stroke Society. Both positions are unpaid.
